Stay updated on LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial

Sign up to get notified when there's something new on the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T23:00:39.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying who to contact for questions and providing information on the study's location, with a revision from v2.12.2 to v2.13.2.
    Difference
    3%
    Check dated 2024-12-07T17:13:49.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The website has added a 'Show less' feature while removing extensive details about participant groups, interventions, and various data fields available for download.
    Difference
    4%
    Check dated 2024-11-23T05:13:41.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Several key health-related resources have been removed, including links to rare disease information, Dailymed, and various government health websites.
    Difference
    0.4%
    Check dated 2024-11-16T00:29:11.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, adding several new resources related to rare diseases and clinical trials, while removing the option to show less information and the previous revision note.
    Difference
    5%
    Check dated 2024-11-08T18:41:20.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.1%
    Check dated 2024-11-01T11:04:23.000Z thumbnail image

Stay in the know with updates to LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page.